MetaCap

Iambic Therapeutics Earnings

NASDAQ: IAMHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

13.11-1.15 (-8.06%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Iambic Therapeutics earnings summary

In its most recent report on Nov 16, 2026 (Sep/2026), IAM posted EPS of $-6.23 versus the $-0.33 consensus estimate, a negative surprise of 1787.9%.

Summary generated from market data by MetaCap's automated system. Methodology

IAM earnings history

Iambic Therapeutics reported EPS versus estimates
Report dateEPS est.EPS actualSurprisePrice reaction
Nov 16, 2026$-0.33$-6.23-1787.9%—

Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.

Related